Vimarsana
Biggest News Aggregation in the World

Page 2 - Resistant Depression News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Resistant Depression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Resistant Depression Today - Breaking & Trending Today

Combining psychotherapy with antidepressants does not improve outcomes in severely depressed patients - Vimarsana News

Combining psychotherapy with antidepressants does not improve outcomes in severely depressed patients

Antidepressants are the first-choice treatment for severe depression. Antidepressant use is often supplemented by psychotherapy.

New Study Doubts Psychotherapy For Depressed On Antidepressants - Vimarsana News

New Study Doubts Psychotherapy For Depressed On Antidepressants

For severe depression, antidepressants are the first line of treatment. Psychotherapy is often used along with antidepressants. Now, findings from a large

Source: revyuh.com
Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry - Vimarsana News

Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry

/PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960) is pleased to announce that its CEO, Dr....

Treatment-Resistant Depression: Other Treatments for Severe Depression - Vimarsana News

Treatment-Resistant Depression: Other Treatments for Severe Depression

Even if your depression does not seem to be responding to drug treatment, there are many other options to reduce or eliminate symptoms. Learn more from WebMD about various therapies available for treatment-resistant depression.

Source: webmd.com
atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform - Vimarsana News

atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform

- Highlights included positive Phase 2b data with COMP360 from a ground-breaking treatment resistant depression (TRD) trial, highly encouraging Phase 2a proof-of-mechanism data with RL-007 in cognitive